Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found
The most common side effects are gastrointestinal, including nausea (1222%), diarrhea (1316%), vomiting (69%), and constipation (67%)
Cell culture and animal studies provide strong mechanistic evidence for telomerase activation and telomere elongation
The label might read "Semaglutide 2.5 mg / Cyanocobalamin 1 mg per mL." The B12 does not change the semaglutide concentration
Oct 23, 2025 2 min read As the FDA cracks down on compounded formulas of weight loss drugs such as Wegovy (semaglutide) and Zepbound (tirzepatide), Americans are turning to unregulated GLP-1 dietary supplements that claim to supercharge the bodys GLP-1 levels to accelerate weight loss